Frontiers in Genetics (Jan 2023)

Targeted next-generation sequencing for genetic variants of left ventricular mass status among community-based adults in Taiwan

  • Hsien-Yu Fan,
  • Hsien-Yu Fan,
  • Wan-Yu Lin,
  • Tzu-Pin Lu,
  • Yun-Yu Chen,
  • Yun-Yu Chen,
  • Yun-Yu Chen,
  • Yun-Yu Chen,
  • Yun-Yu Chen,
  • Justin BoKai Hsu,
  • Sung-Liang Yu,
  • Ta-Chen Su,
  • Hung-Ju Lin,
  • Yang-Ching Chen,
  • Yang-Ching Chen,
  • Yang-Ching Chen,
  • Yang-Ching Chen,
  • Kuo-Liong Chien,
  • Kuo-Liong Chien

DOI
https://doi.org/10.3389/fgene.2022.1064980
Journal volume & issue
Vol. 13

Abstract

Read online

Background: Left ventricular mass is a highly heritable disease. Previous studies have suggested common genetic variants to be associated with left ventricular mass; however, the roles of rare variants are still unknown. We performed targeted next-generation sequencing using the TruSight Cardio panel, which provides comprehensive coverage of 175 genes with known associations to 17 inherited cardiac conditions.Methods: We conducted next-generation sequencing using the Illumina TruSight Cardiomyopathy Target Genes platform using the 5% and 95% extreme values of left ventricular mass from community-based participants. After removing poor-quality next-generation sequencing subjects, including call rate <98% and Mendelian errors, 144 participants were used for the analysis. We performed downstream analysis, including quality control, alignment, coverage length, and annotation; after setting filtering criteria for depths more than 60, we found a total of 144 samples and 165 target genes for further analysis.Results: Of the 12,287 autosomal variants, most had minor allele frequencies of <1% (rare frequency), and variants had minor allele frequencies ranging from 1% to 5%. In the multi-allele variant analyses, 16 loci in 15 genes were significant using the false discovery rate of less than .1. In addition, gene-based analyses using continuous and binary outcomes showed that three genes (CASQ2, COL5A1, and FXN) remained to be associated with left ventricular mass status. One single-nucleotide polymorphism (rs7538337) was enriched for the CASQ2 gene expressed in aorta artery (p = 4.6 × 10–18), as was another single-nucleotide polymorphism (rs11103536) for the COL5A1 gene expressed in aorta artery (p = 2.0 × 10–9). Among the novel genes discovered, CASQ2, COL5A1, and FXN are within a protein–protein interaction network with known cardiovascular genes.Conclusion: We clearly demonstrated candidate genes to be associated with left ventricular mass. Further studies to characterize the target genes and variants for their functional mechanisms are warranted.

Keywords